Treatment with pravastatin attenuates progression of chronic pancreatitis in rat

Laboratory Investigation

Volumn 91, Issue 6, 2011, Pages 872-884

  Wei, Limin ^a   Yamamoto, Mitsuyoshi ^a,c   Harada, Masaru ^a   Otsuki, Makoto ^a,b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KOBE WOMEN'S UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

fibrosis; HMG CoA reductase; inflammation; oxidative stress; pancreas

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; MYELOPEROXIDASE; PRAVASTATIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DUODENUM; HYPERTENSION; MALE; NONHUMAN; PANCREAS FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; FIBROSIS; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; MALE; PANCREATITIS, CHRONIC; PRAVASTATIN; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957588823     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.41     Document Type: Article

References (50)

1. Endo A, Kuroda M, Tanzawa K. Competitive inhibition of 3-hydroxy-3- methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett 1976;72:323-326. (Pubitemid 8017240)
2. Solheim S, Seljeflot I, Arnesen H, et al. Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis 2001;157:411-415. (Pubitemid 32710020)
3. Li C, Yang CW, Park JH, et al. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Am J Physiol Renal Physiol 2004;286:F46-F57. (Pubitemid 38045041)
4. Moriyama T, Kawada N, Nagatoya K, et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 2001;59:2095-2103. (Pubitemid 32467601)
5. Hartner A, Klanke B, Cordasic N, et al. Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate- salt hypertension. J Hypertens 2009;27: 376-385.
6. Joyce M, Kelly C, Winter D, et al. Pravastatin, a 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion. J Surg Res 2001;101:79-84. (Pubitemid 33030111)
7. Ni W, Egashira K, Kataoka C, et al. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ Res 2001;89: 415-421. (Pubitemid 34132657)
8. Yu Y, Ohmori K, Chen Y, et al. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model. J Am Coll Cardiol 2004;44:904-913. (Pubitemid 39099592)
9. Ercan F, Gedik N, et al. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 2007;230:256-264. (Pubitemid 46109145)
10. Otani M, Yamamoto M, Harada M, et al. Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka Long-Evans Tokushima Fatty rat. Br J Pharmacol 2010;159:462-473.
11. Yamamoto M, Otani M, Otsuki M. A new model of chronic pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 2006;291:G700-G708. (Pubitemid 44511687)
12. Green GM, Nasset ES. Importance of bile in regulation of intraluminal proteolytic enzyme activities in the rat. Gastroenterology 1980;79: 695-702.
13. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1985;193:265-275.
14. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-352. (Pubitemid 10115803)
15. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions. Clin Chim Acta 1969;26:437-444.
16. Ukeda H, Shimamura T, Tsubouchi M. Spectrophotometric assay of superoxide anion formed in Maillard reaction based on highly watersoluble tetrazolium salt. Anal Sci 2002;18:1151-1154.
17. Bhatia M, Ramnath RD, Chevali L, et al. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005;288:G1259-G1265. (Pubitemid 40741080)
18. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996;29:225-229. (Pubitemid 26142071)
19. Neuman RE, Logan MA. The determination of hydroxyproline. J Biol Chem 1950;184:299-306.
20. Korc M, Chandrasekar B, Yamanaka Y, et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90:1352-1360.
21. Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998;43: 128-133. (Pubitemid 28335501)
22. Naruse I, Keino H, Kawarada Y. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry 1994;101:73-78. (Pubitemid 24103990)
23. Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-20-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetateinduced renal carcinogenesis model. Lab Invest 1997;76:365-374. (Pubitemid 27157344)
24. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin- biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-821. (Pubitemid 11063879)
25. Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 1997;100: 1853-1862. (Pubitemid 27431345)
26. Villarreal FJ, MacKenna DA, Omens JH, et al. Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension 1995;25: 98-104.
27. Bachem MG, Meyer D, Melchior R, et al. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992;89:19-27.
28. Oemar BS, Werner A, Garnier JM, et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997;95:831-839. (Pubitemid 27091522)
29. Sola S, Mir MQ, Lerakis S, et al. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 2006;47:332-337. (Pubitemid 43063250)
30. Schoenberg MH, Bü chler M, Pietrzyk C, et al. Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas 1995;10:36-43.
31. Matsumura N, Ochi K, Ichimura M, et al. Study on free radicals and pancreatic fibrosis-pancreatic fibrosis induced by repeated injections of superoxide dismutase inhibitor. Pancreas 2001;22:53-57. (Pubitemid 32046215)
32. Gómez JA, Molero X, Vaquero E, et al. Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2004;287:G162-G169. (Pubitemid 38802130)
33. Habibi J, Whaley-Connell A, Qazi MA, et al. Rosuvastatin, a 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Endocrinology 2007;148:2181-2188. (Pubitemid 46997071)
34. de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174: 1209-1220.
35. Eller P, Eller K, Wolf AM, et al. Atorvastatin attenuates murine antiglomerular basement membrane glomerulonephritis. Kidney Int 2010;77:428-435.
36. Bachem MG, Schneider E, Gross H, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998;115:421-432.
37. Apte MV, Haber PS, Darby SJ, et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 1999;44:534-541. (Pubitemid 29169954)
38. Mews P, Phillips P, Fahmy R, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 2002;50:535-541. (Pubitemid 34638875)
39. Asaumi H, Watanabe S, Taguchi M, et al. Green tea polyphenol (-)- epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells. Eur J Clin Invest 2006;36:113-122.
40. Eberlein M, Heusinger-Ribeiro J, Goppelt-Struebe M. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Br J Pharmacol 2001;133: 1172-1180. (Pubitemid 32762429)
41. Jaster R, Brock P, Sparmann G, et al. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol 2003;65:1295-1303. (Pubitemid 36407781)
42. Manna SK, Zhang HJ, Yan T, et al. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 1998;273:13245-13254. (Pubitemid 28246897)
43. Zhang XP, Lin Q, Zhou YF. Progress of study on the relationship between mediators of inflammation and apoptosis in acute pancreatitis. Dig Dis Sci 2007;52:1199-1205. (Pubitemid 46626175)
44. Paniagua JA, Lopez-Miranda J, Escribano A, et al. Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes. Diabetes 2002;51:2596-2603. (Pubitemid 34827412)
45. Haydont V, Bourgier C, Pocard M, et al. Pravastatin Inhibits the Rho/ CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res 2007;13:5331-5340. (Pubitemid 47510357)
46. Chang SA, Kim YJ, Lee HW, et al. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy. Hypertension 2009;54:591-597.
47. Tsigrelis C, Pitchumoni CS. Pravastatin: a potential cause for acute pancreatitis. World J Gastroenterol 2006;12:7055-7057. (Pubitemid 44834902)
48. Anagnostopoulos GK, Tsiakos S, Margantinis G, et al. Acute pancreatitis due to pravastatin therapy. JOP 2003;4:129-132. (Pubitemid 38963789)
49. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 2003;17:887-893. (Pubitemid 36459601)
50. Thisted H, Jacobsen J, Munk EM, et al. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 2006;23:185-190. (Pubitemid 43381182)